Zydus

Cadila board approves transfer of animal healthcare arm to Zydus Health

The transfer of animal healthcare business is through execution of a definitive agreement, Cadila Healthcare said in a filing to BSE

Sugar Free's bitter battle with online misinformation, competitive brands

To become part of the consumer's monthly shopping cart, Sugar Free has launched new formats and variants and waged war against online venom

Zydus receives tentative approval from USFDA for Tofacitinib tablets

It helps to decrease pain, tenderness and swelling in the joints

Zydus gets regulatory nod to sell diabetes drug in Mexico

Lipaglyn, a prescription drug, was first launched in India during September 2013, Zydus said

Zydus gets USFDA nod to market Tranexamic acid injection

The injection is used to prevent bleeding in patients with hemophilia undergoing tooth extraction

Zydus' Nesher Pharma gets US FDA nod for antifungal drug

The drug will be produced at Nesher Pharmaceuticals manufacturing facility in USA

Zydus Cadila acquires 6 brands from American pharma MSD

These fall in men's health, women's health, cardiovascular and wound management therapy segments

Zydus can launch ulcer drug in US, patent litigation settled

The patent litigation relating to Allergan's Delzicol has been settled, Zydus Cadila said in a statement

Zydus to launch immunosupressant drug Grafalon

The market for transplant-immuno therapies is estimated at Rs 483 crore

Zydus acquires derma brand Melgain from Issar Pharma

The brand will be marketed by Liva Healthcare, the group's division catering to dermatological segment

Zydus gets FDA nod for anti-viral Acyclovir capsules

This would be the third drug approval for the US markets for the Group this year apart from a tentative approval